The Danish pharma and biotech industry is among the best and most innovative in the world. As the European leader in drug development, Denmark offers attractive business solutions for foreign biotech companies including R&D collaborations, establishing European headquarters or entering strategic partnerships. The Danish biotechnology cluster is a major world player, especially in areas such as inflammatory and infectious diseases, CNS research, diabetes care and cancer research.
A number of favourable framework conditions means that a fast, safe and cost-effective drug discovery and drug development is a reality in Denmark, which also is one of the fastest countries to approve clinical trials. In short, Denmark is the place to perform drug discovery and development.